Details for New Drug Application (NDA): 008492
✉ Email this page to a colleague
The generic ingredient in ANTRENYL is oxyphenonium bromide. Additional details are available on the oxyphenonium bromide profile page.
Summary for 008492
Tradename: | ANTRENYL |
Applicant: | Novartis |
Ingredient: | oxyphenonium bromide |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 008492
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Complete Access Available with Subscription